Drug Trial Radar · NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
460
Planned (sponsor's estimate)
Start
Apr 17, 2026
Primary completion
Sep 2028
Study completion Feb 2030
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in patients with previously treated blood cancers. For each participant, the study could last about 9 months or possibly longer including screening.
Conditions
- Lymphoma, Non-Hodgkin's
- Lymphoma, Diffuse Large B-Cell
- Follicular Lymphoma
Interventions
LY4584180Drug
administered orally
RituximabDrug
administered through IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Dose-Limiting Toxicities (DLTs) and DLT-Equivalent ToxicitiesTime frame: Baseline up to Day 28
- Number of Participants with One or More Serious Adverse Events (SAEs) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline up to 3 Years
- To Evaluate the Preliminary Antitumor Activity of LY4584180: Objective Response Rate (ORR)Time frame: Baseline up to 3 Years
Locations
46 sites in 8 countries. Site status is shown where the registry gives one.
Mayo Clinic - Scottsdale
Scottsdale, Arizona · Recruiting
City of Hope
Duarte, California · Recruiting
University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, California · Recruiting
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
San Francisco, California · Recruiting
Colorado Blood Cancer Institute
Denver, Colorado · Recruiting
University of Miami - Sylvester Cancer Center
Miami, Florida · Recruiting
Florida Cancer Specialists - Sarasota
Sarasota, Florida · Recruiting
Emory University Hospital
Atlanta, Georgia · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Mayo Clinic - Rochester
Rochester, Minnesota · Recruiting
Columbia University
New York, New York · Recruiting
University of Rochester
Rochester, New York · Recruiting
The Ohio State University (OSU)
Columbus, Ohio · Recruiting
Oregon Health & Science University (OHSU)
Portland, Oregon · Not yet recruiting
Sarah Cannon Research Institute
Nashville, Tennessee · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
Texas Oncology - DFW (Sammons CC)
Dallas, Texas · Recruiting
Baylor College of Medicine
Houston, Texas · Not yet recruiting
University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance)
Seattle, Washington · Recruiting
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
CHU de Nantes - Hotel-Dieu
Nantes, France · Not yet recruiting
Institut Curie
Paris, France · Not yet recruiting
CHU Bordeaux - Hopital Haut-Leveque - Centre Francois Magendie
Pessac, France · Not yet recruiting
HCL Centre Hospitalier Lyon Sud
Pierre-Bénite, France · Not yet recruiting
Oncopole Claudius Regaud
Toulouse, France · Not yet recruiting
Charite Universitaetsmedizin Berlin
Berlin, Germany · Not yet recruiting
Universitaetsklinikum Koeln (AoeR)
Cologne, Germany · Not yet recruiting
Universitaetsklinikum Essen
Essen, Germany · Not yet recruiting
Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet
Frankfurt am Main, Germany · Not yet recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola
Bologna, Italy · Not yet recruiting
Istituto Europeo di Oncologia
Milan, Italy · Not yet recruiting
National Cancer Center Hospital East
Chiba, Japan · Not yet recruiting
Okayama University Hospital
Okayama, Japan · Recruiting
Cancer Institute Hospital of JFCR
Tokyo, Japan · Recruiting
Pratia Onkologia Katowice
Katowice, Poland · Not yet recruiting
Pratia MCM Krakow
Krakow, Poland · Not yet recruiting
AIDPORT Sp. z o.o.
Skorzewo, Poland · Not yet recruiting
Instytut Hematologii i Transfuzjologii w Warszawie
Warsaw, Poland · Not yet recruiting
Institut Catala d'Oncologia - L'Hospitalet
Barcelona, Spain · Not yet recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.